Major cancer trial tests breakthrough drug combos for Tough-to-Treat esophageal tumors
NCT ID NCT04821778
Summary
This large study aims to find the best treatment combination for patients with esophageal or stomach junction cancer that cannot be surgically removed. Researchers will test whether adding newer immunotherapy drugs or targeted therapies to standard chemotherapy and radiation improves survival for 2,000 participants. The goal is to determine which treatment approach helps patients live longer while managing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department 4th of Radiation Oncology, Anyang Cancer Hospital
RECRUITINGAnyang, Henan, 455001, China
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
RECRUITINGBeijing, 100021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Radiation oncology, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The affiliated Cancer Hospital of Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210009, China
Contact
-
Department of Radiation oncology, Jiangsu Province Hospital/The First Affiliated Hospital with Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210029, China
Contact Email: •••••@•••••
Contact
-
Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
RECRUITINGChangsha, Hunan, 410031, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.